The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), General Mills (NYSE:GIS), Newmont Corp (NYSE:NEM), Kroger Co (The) (NYSE:KR).
The investment seeks capital appreciation.
The fund invests, under normal market conditions, at least 80% of its assets in U.S. equity securities. It pursues its objective by seeking to track the total return, before fees and expenses, of the TOBAM Anti-Benchmark® US Core Equity Index. The index is a proprietary rules-based index created by the fund's sub-advisor, TOBAM S.A.S., that is designed to create a more diversified equity portfolio of U.S. equity securities relative to traditional market capitalization weighted benchmarks.
The average market capitalization across the Touchstone Anti-Benchmark US Core Eq C MF is 70.34B. The market cap for tickers in the group ranges from 15.89B to 419.89B. LLY holds the highest valuation in this group at 419.89B. The lowest valued company is SJM at 15.89B.
The average weekly volume growth across all stocks in the Touchstone Anti-Benchmark US Core Eq C MF was 10%. For the same stocks of the MF, the average monthly volume growth was -11% and the average quarterly volume growth was 22%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 35
P/E Growth Rating: 52
Price Growth Rating: 52
SMR Rating: 46
Profit Risk Rating: 40
Seasonality Score: 16 (-100 ... +100)